While no formal exhibition, the conference features private, pre-arranged one-on-one meetings between senior-level executives, using BIO's proprietary, state-of-the-art computer software. The format and selective nature of the conference makes this the premier dedicated biotech partnering event in Asia and an unrivaled opportunity to meet with the leading international pharmaceutical and biotech companies in one place at one time.
The 15th Annual BIO Asia International Conference is an exclusive, customized partnering forum that brings together U.S. and European drug development companies with Asian biotech and pharmaceutical companies interested in research collaborations and licensing agreements.
The 9th annual Biopharma Asia Convention 2016 brings together C-level attendees from pharmas, biotecs and service providers to learn and discuss market trends and biologic development strategies.
Asia's biopharma industry is growing, and growing fast. With technical expertise, low manufacturing costs and improving regulatory frameworks, its value will soon run into the hundreds of billions of dollars. Are you making the most of the opportunity?
New vaccine technologies to boost production and and speed up development and delivery to the market.
The ONLY Vaccine event in China for developing and emerging country vaccine leaders!
Vaccine World Summit is the most sought after vaccine industrial gathering for developing country manufacturers. Led by overwhelming demand from the industry, we are bringing the event to CHINA in 2013.
Vaccine World China 2013 will be THE DEFINITE meeting place for vaccine leaders from China and all around the world. Produced by the same team behind the successful Vaccine World Summit India, Vaccine World China 2013 promises to be a splendid experience that you do not want to miss.
Biopharma China Congress 2011 & VacTech 2011, which were first organized by JFPS Group in the year of 2011 separately, have successfully attracted more than 280 professionals from over 140 companies in the biopharmaceutical and vaccine industry. Over 45 senior speakers from the leading biopharmaceutical and vaccine companies worldwide have been invited to share their experience in vaccine R&D and manufacturing and biopharma R & D partnering and trials.
The largest orphan drug conference in Asia to bring together industry leaders from big pharmas, biotechs, government and research organizations to address the opportunities and challenges for commercialization and market potential for drugs to treat rare diseases.